Trial Profile
Rosuvastatin Pharmacokinetic (PK) Study in Caucasian and Asian Morbid Obese Patients
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacokinetics
- Acronyms RST
- 15 Jan 2020 Status changed from recruiting to discontinued.
- 27 Apr 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 19 Aug 2014 New trial record